Althea Medical Journal
Vol 5, No 4 (2018)

Is Zuspan Regimen Adequate for Preventing Eclampsia?: A Case Report

Raymond Surya (Department of Obstetrics and Gynecology, Faculty of Medicine Universitas Indonesia/Dr. Cipto Mangunkusumo Hospital Jakarta)
Budi Iman Santoso (Department of Obstetrics and Gynecology, Faculty of Medicine Universitas Indonesia/Dr. Cipto Mangunkusumo Hospital Jakarta)
Surahman Hakim (Department of Obstetrics and Gynecology, Faculty of Medicine Universitas Indonesia/Dr. Cipto Mangunkusumo Hospital Jakarta)



Article Info

Publish Date
31 Dec 2018

Abstract

Magnesium sulphate (MgSO4) is believed to treat preeclampsia and eclampsia for more than a century with a total dose of MgSO4 varying from 2 to 5g per 24 hours. Zuspan and Pritchard are two internationally recommended regimens that are accepted as the standard regimen. In this case report, we presented a 41 year old woman with puerperal preeclampsia prescribed with a complete Zuspan regimen. She had eclamptic seizure after completing Zuspan regimen with Mg SO4 level of 4.3 mg/dL. In this case, the possibility of eclamptic seizures might be due to a lack of MgSO4 dose. The administration of MgSO4 for preeclampsia with severe features and prophylactic of eclampsia should be adjusted.  

Copyrights © 2018






Journal Info

Abbrev

amj

Publisher

Subject

Medicine & Pharmacology

Description

Althea Medical Journal (AMJ) is a peer reviewed electronic scientific publication journal which is published every 3 months (March, June, September, and December). Althea Medical Journal publishes articles related to research in biomedical sciences, clinical medicine, family-community medicine, and ...